Organelle-targeting activity-based hemicyanine derivatives for enhanced and selective type-I photodynamic therapy under hypoxia conditions
Two organelle-targeted and hydrogen sulfide responsive type-I photodynamic therapy agents are developed for selective and effective treatment of hypoxic cancer cells.
Authors
- Hande Gündüz (ORCID: https://orcid.org/0000-0001-7828-892X)
- Yunus Akkoç (ORCID: https://orcid.org/0000-0001-5379-6151)
- Safacan Kölemen (ORCID: https://orcid.org/0000-0003-4162-5587)
- Devrim Gözüaçık (ORCID: https://orcid.org/0000-0001-7739-2346)
- Musa Dirak (ORCID: https://orcid.org/0000-0002-2085-2345)
- Alperen Acari (ORCID: https://orcid.org/0009-0006-8196-0557)
- Haluk Samet Kocak (ORCID: https://orcid.org/0000-0001-9212-9837)
- Ayca Saymaz
- Cansu M. Yenici
Institutions
- Koç University (TR)
- Istanbul Technical University (TR)
Publication Details
- Journal
- Materials Chemistry Frontiers
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1039/d4qm00744a
- Citations
- 9
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.77